Literature DB >> 7197476

Postoperative pain relief by epidural morphine.

N Rawal, U Sjöstrand, B Dahlström.   

Abstract

Postoperative pain relief was studied in 280 patients undergoing various kinds of surgery, e.g., thoracic, upper and lower abdominal, perineal, obstetric, and orthopedic. Morphine, 2 or 4 mg, was given after surgery through an indwelling epidural catheter. Excellent analgesia was noted in 87% of patients; only 3.5% of patients were dissatisfied. A single injection gave complete pain relief for the entire postoperative period in 30% of cases; in the remaining patients the mean duration of analgesia was 10.7 hours (SD +/- 4.3). Plasma morphine concentrations recorded after 2-mg doses suggest a regional spinal action as the basis for the long duration of analgesia, although the initial effect after 4-mg doses might well include systemic responses due to rapid vascular uptake of morphine from the epidural space. Peak expiratory flow (PEF) measurements and arterial blood gas analyses showed no significant early postoperative respiratory depression. Absence of sedation, orthostatic hypotension, respiratory depression, and motor paralysis facilitated early ambulation with less risk for postoperative respiratory complications. It is concluded that 2-mg doses of epidural morphine give good analgesia of long duration despite low plasma levels. After upper abdominal and thoracic surgery higher doses (4 mg) may be necessary in healthy patients. Elderly and frail patients appear to be sensitive to epidural morphine and doses in excess of 2 mg should be avoided regardless of the type of surgery. With this dose schedule we have not encountered delayed respiratory depression.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7197476

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

Review 1.  Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.

Authors:  Martin S Angst; David R Drover
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Epidural morphine prophylaxis of postoperative pain: report of a double-blind multicentre study.

Authors:  W D Writer; J B Hurtig; D Evans; R E Needs; C E Hope; J B Forrest
Journal:  Can Anaesth Soc J       Date:  1985-07

3.  Epidural morphine does not affect the duration of action of epidural 2-chloroprocaine following Caesarean section.

Authors:  G Z Brooks; Y Donchin; J G Collins; L M Kitahata; S A Jefferson
Journal:  Can Anaesth Soc J       Date:  1983-11

4.  Accidental epidural narcotic overdose.

Authors:  R J Robinson; S Lenis; M Elliot
Journal:  Can Anaesth Soc J       Date:  1984-09

5.  Intraspinal opiates and itching: a new reflex?

Authors:  D M Justins; F Reynolds
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-08

6.  [The clinical use of spinal opioids, part 1].

Authors:  N Rawal
Journal:  Schmerz       Date:  1996-08-26       Impact factor: 1.107

7.  Epidural and intrathecal morphine in intensive care units.

Authors:  N Rawal; B Tandon
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

8.  Post-caesarean section analgesia: a comparison of epidural butorphanol and morphine.

Authors:  Q T Palacios; M M Jones; J L Hawkins; J N Adenwala; S Longmire; K R Hess; B S Skjonsby; D H Morrow; T H Joyce
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

9.  Does epidural morphine loading in addition to thoracic epidural analgesia benefit the postoperative management of morbidly obese patients undergoing open bariatric surgery? A pilot study.

Authors:  Anastasia Zotou; Athina Siampalioti; Panagiota Tagari; Leonidas Paridis; Fotis Kalfarentzos; Kriton S Filos
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

Review 10.  The management of postsurgical pain in the elderly population.

Authors:  J Richardson; K Bresland
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.